Earnings

Danaher returns a key business to growth, and we’re raising our stock rating back to buy

Products You May Like

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

Products You May Like

Articles You May Like

British fintech firm Wise posts 55% jump in profit on expanding market share
China urges U.S. cooperation as Trump trade threat looms
Lucid slightly tops Wall Street’s third-quarter expectations amid widening losses
Solar stocks tumble on fears Trump will hamper clean energy progress, repeal IRA
Nissan shares plunge over 10% after downbeat quarterly results, production-cut plans

Leave a Reply

Your email address will not be published. Required fields are marked *